ASX:ALX Atlas Arteria (ALX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Atlas Arteria Stock (ASX:ALX) 30 days 90 days 365 days Advanced Chart Get Atlas Arteria alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.69 million shsAverage VolumeN/AMarket CapitalizationA$7.33 billionP/E Ratio31.31Dividend Yield7.92%Price TargetN/AConsensus RatingN/A Company Overview Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia. Read More Receive ALX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ALX Stock News HeadlinesAtlas Arteria Limited (ASX:ALX) is largely controlled by institutional shareholders who own 77% of the companyAugust 20, 2025 | finance.yahoo.comWhy Macquarie expects this high-yielding ASX 200 dividend stock to outperformJuly 31, 2025 | msn.comSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split the entire U.S. market in two on or before Sept 30, causing a crisis "many times worse than 2008."August 28 at 2:00 AM | Altimetry (Ad)Atlas Arteria retreats after US toll rates setbackJuly 19, 2025 | msn.comWhy 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling todayJuly 18, 2025 | msn.comAtlas Arteria Stock Price History - Investing.comJune 26, 2025 | investing.comAtlas Arteria records 6.1% jump in Q1 toll revenueApril 23, 2025 | msn.comASX Market Close: Index pares gains to close flat | March 25, 2025March 25, 2025 | msn.comSee More Headlines ALX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Atlas Arteria own? Based on aggregate information from My MarketBeat watchlists, some other companies that Atlas Arteria investors own include Adairs (ADH), AMA Group (AMA), ANZ Group (ANZ), Commonwealth Bank of Australia (CBA), Fortescue (FMG), Gilead Sciences (GILD) and Industry, Sector and Symbol Stock ExchangeASX SectorIndustrials Industry Infrastructure Operations Sub-IndustryTrading Current SymbolASX:ALX CIKN/A Webwww.atlasarteria.com Phone61 2 8232 7455FaxN/AEmployees70Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.21 Trailing P/E Ratio31.31 Forward P/E RatioN/A P/E Growth0.31Net IncomeA$300.20 million Net Margins167.02% Pretax MarginN/A Return on Equity3.79% Return on Assets-0.06% Debt Debt-to-Equity Ratio27.23 Current Ratio2.26 Quick Ratio1.77 Sales & Book Value Annual SalesA$140.10 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.65 Book ValueA$4.21 per share Price / BookN/AMiscellaneous Outstanding Shares1,450,000,000Free FloatN/AMarket CapA$7.33 billion OptionableNot Optionable Beta0.78 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (ASX:ALX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlas Arteria Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlas Arteria With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access